THYMIDYLATE SYNTHASE HAPLOTYPE IS ASSOCIATED WITH TUMOR RECURRENCE IN STAGE II AND STAGE III COLON CANCER PATIENTS

摘要

The invention provides compositions and methods for determining the likelihood of tumor recurrence following treatment with 5-FU based adjuvant therapy for Stage II or Stage III colon cancer patients. After determining if a patient is less likely to experience tumor recurrence once treated, the invention also provides methods for treating these patients.